Biotech & pharma
European Court of Justice delivers a blow to stem cell research
19 Oct 2011
The ruling does not prevent scientists experimenting with cells plucked from human embryos, which destroys the embryo, but removes a key commercial incentive for biotech and pharma companies for supporting stem-cell research.
Tiny stamps for tiny sensors
By Jennifer Chu, MIT News Office | 19 Oct 2011
Research finds normal brain communication in patients with agenesis of the corpus callosum
19 Oct 2011
Research reveals novel aspects of virus-fighting protein
By By Eric Gershon | 17 Oct 2011
The secret life of cells — in colour
15 Oct 2011
Analysis of 29 mammals reveals genomic ‘dark matter’
By By Haley Bridger, Broad Institute | 13 Oct 2011
Genomic comparison offers a new map for charting human disease and biology.
Shutting off inflammation
By By Anne Trafton, MIT News Office | 11 Oct 2011
New inherited neurometabolic disorder discovered
03 Oct 2011
Roads pave the way for the spread of superbugs
30 Sep 2011
Mimicking cells with transistors
By By Larry Hardesty, MIT News Office | 28 Sep 2011
Analogue — rather than digital — circuits could enable models of biological systems that are more efficient, more accurate and easier to build.
Researchers build cardiac tissue using gold nanowires for heart attack patients
By Emily Finn, MIT News Office | 26 Sep 2011
New cardiac patch uses gold nanowires to enhance electrical signaling between cells, a promising step toward better treatment for heart-attack patients.
Latest articles
Featured articles
.webp)
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.
